Psychiatric Times October 15, 2024
Steven E. Hyler, MD

Learn more about how AI can transform mental health care.

CHATBOT CORNER

The pharmaceutical industry is in the midst of a transformative revolution driven by advancements in large language models (LLMs), generative artificial intelligence (AI), and chatbots. These technologies offer unprecedented opportunities to enhance clinical trials, streamline the dissemination of pharmaceutical information, and accelerate drug discovery.1 In this manuscript, we explore how AI is being utilized to improve efficiency, ensure better patient outcomes, and revolutionize communication strategies in the pharmaceutical landscape. Furthermore, we delve into the current challenges and opportunities of AI integration and highlight significant AI investments in the industry.

Enhancing Clinical Trials with Generative AI

Clinical trials are the backbone of pharmaceutical research, providing the evidence needed to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Biotechnology, Clinical Trials, Mental Health, Pharma, Pharma / Biotech, Provider, Technology, Trends
Related Articles:
How To Smartly (And Safely) Leverage GenAI In Business
Chinese AI startup DeepSeek unveils open-source model to rival OpenAI o1
The Next Frontier For Smart Glasses: Empowering Vision With On-Device AI
Boosting AI at the VA
Fair Use Of Generative AI: Why Its Plausibility Is Questionable

Share This Article